Income Statement PharmaCorp Rx Inc.

Stocks

PCRX

CA71714X1050

Drug Retailers

Market Closed - Toronto S.E. Other stock markets 23:58:03 27/07/2026 +04			5-day change	1st Jan Change
0.4800 ^CAD	-2.04%		-5.88%	+5.49%

07-14	PharmaCorp to Seek Acquisition Opportunities	CI
07-14	PharmaCorp Rx Closes C$11.5 Million Bought-Deal Offering of Share Units	MT

d61b51.BXCuFo7FmlRzI2JoiyRPs4i3rUFRVaNa_Zb5bYTX0A4.SSL9cdu28g4mdzoE4VEf9OeD3zBnO_MSlMaNX82kvmtGHPRZ2YL7IUESVg

Published financial data: PHARMACORP RX INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	-	-	-	5.79M	20.89M
Total Revenues	-	-	-	5.79M	20.89M
Cost of Goods Sold, Total	-	-	-	3.61M	12.6M
Gross Profit	-	-	-	2.18M	8.3M
Selling General & Admin Expenses, Total	79.6K	177K	578K	3.2M	8.19M
Stock-Based Compensation (IS)	-	386K	-	283K	406K
Depreciation & Amortization - (IS)	-	-	-	290K	940K
Other Operating Expenses, Total	79.6K	563K	578K	3.77M	9.54M
Operating Income	-79.6K	-563K	-578K	-1.59M	-1.24M
Interest Expense, Total	-	-	-	-14.26K	-56.86K
Interest And Investment Income	2.14K	46.09K	108K	381K	294K
Net Interest Expenses	2.14K	46.09K	108K	367K	237K
Other Non Operating Income (Expenses)	-	-	-	63.96K	165K
EBT, Excl. Unusual Items	-77.45K	-517K	-470K	-1.16M	-836K
EBT, Incl. Unusual Items	-77.45K	-517K	-470K	-1.16M	-836K
Income Tax Expense	-	-	-	-106K	586K
Earnings From Continuing Operations	-77.45K	-517K	-470K	-1.05M	-1.42M
Net Income to Company	-77.45K	-517K	-470K	-1.05M	-1.42M
Minority Interest	-	-	-	38.11K	-59.3K
Net Income - (IS)	-77.45K	-517K	-470K	-1.01M	-1.48M
Net Income to Common Incl Extra Items	-77.45K	-517K	-470K	-1.01M	-1.48M
Net Income to Common Excl. Extra Items	-77.45K	-517K	-470K	-1.01M	-1.48M
Per Share Items
Net EPS - Basic	-	-0.03	-0.02	-0.01	-0.01
Basic EPS - Continuing Operations	-	-0.03	-0.02	-0.01	-0.01
Basic Weighted Average Shares Outstanding	16.2M	20M	20.28M	81.73M	125M
Net EPS - Diluted	-	-0.03	-0.02	-0.01	-0.01
Diluted EPS - Continuing Operations	-	-0.03	-0.02	-0.01	-0.01
Diluted Weighted Average Shares Outstanding	16.2M	20M	20.28M	81.73M	125M
Normalized Basic EPS	-	-0.02	-0.01	-0.01	-0
Normalized Diluted EPS	-	-0.02	-0.01	-0.01	-0
Supplemental Items
EBITDA	-	-	-	-1.35M	-415K
EBITA	-79.6K	-563K	-578K	-1.42M	-581K
EBIT	-79.6K	-563K	-578K	-1.59M	-1.24M
Total Revenues (As Reported)	2.14K	46.09K	108K	-	-
Effective Tax Rate - (Ratio)	-	-	-	9.2	-70.14
Total Current Taxes	-	-	-	31.19K	729K
Total Deferred Taxes	-	-	-	-138K	-142K
Normalized Net Income	-48.41K	-323K	-294K	-685K	-582K
Interest on Long-Term Debt	-	-	-	32.43K	63.95K
Supplemental Operating Expense Items
General and Administrative Expenses	79.6K	177K	578K	1.88M	3.31M
Stock-Based Comp., Other (Total)	-	386K	-	283K	406K
Total Stock-Based Compensation	-	386K	-	283K	406K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	980K	2.73M	2.24M	12.89M	25.89M
Total Cash And Short Term Investments	980K	2.73M	2.24M	12.89M	25.89M
Accounts Receivable, Total	-	-	-	327K	1.22M
Total Receivables	-	-	-	327K	1.22M
Inventory	-	-	-	1.31M	2.71M
Prepaid Expenses	-	-	-	48.03K	80.85K
Other Current Assets, Total	20.5K	-	78.75K	-	-
Total Current Assets	1M	2.73M	2.32M	14.57M	29.89M
Gross Property Plant And Equipment	-	-	-	4.14M	5.72M
Accumulated Depreciation	-	-	-	-118K	-236K
Net Property Plant And Equipment	-	-	-	4.02M	5.48M
Goodwill	-	-	-	11.48M	18.6M
Other Intangibles, Total	-	-	-	5.13M	11.6M
Total Assets	1M	2.73M	2.32M	35.21M	65.57M
Liabilities
Accounts Payable, Total	26.34K	16.46K	46.18K	1.54M	5.2M
Current Portion of Long-Term Debt	-	-	-	75.41K	392K
Current Portion of Leases	-	-	-	73.97K	153K
Current Income Taxes Payable	-	-	-	10.52K	62.47K
Total Current Liabilities	26.34K	16.46K	46.18K	1.7M	5.81M
Long-Term Debt	-	-	-	318K	3.09M
Long-Term Leases	-	-	-	485K	912K
Deferred Tax Liability Non Current	-	-	-	2.14M	3.49M
Total Liabilities	26.34K	16.46K	46.18K	4.64M	13.3M
Common Stock, Total	1M	2.74M	2.8M	31.7M	50.95M
Additional Paid In Capital	-	517K	489K	675K	2.01M
Retained Earnings	-25.82K	-543K	-1.01M	-2.03M	-3.14M
Comprehensive Income and Other	-	-	-	-	2.11M
Total Common Equity	974K	2.72M	2.27M	30.34M	51.92M
Minority Interest	-	-	-	222K	348K
Total Equity	974K	2.72M	2.27M	30.57M	52.27M
Total Liabilities And Equity	1M	2.73M	2.32M	35.21M	65.57M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	16.2M	20M	20.28M	117M	174M
ECS Total Common Shares Outstanding	16.2M	20M	20.28M	117M	174M
Book Value / Share	0.06	0.14	0.11	0.26	0.3
Tangible Book Value	974K	2.72M	2.27M	13.73M	21.72M
Tangible Book Value Per Share	0.06	0.14	0.11	0.12	0.12
Total Debt	0	0	0	953K	4.55M
Net Debt	-980K	-2.73M	-2.24M	-11.93M	-21.34M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	222K	348K
Account Code - Inventory Valuation	3	3	3	6	6
Inventories - Raw Materials, Total	-	-	-	44.25K	47.64K
Inventories - Others	-	-	-	1.27M	2.66M
Land - (BS)	-	-	-	250K	364K
Buildings, Total	-	-	-	2.85M	3.7M
Machinery, Total	-	-	-	127K	290K
Full Time Employees	-	-	-	-	5

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-77.45K	-517K	-470K	-1.01M	-1.48M
Depreciation & Amortization - CF	-	-	-	118K	283K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	172K	657K
Depreciation & Amortization, Total	-	-	-	290K	940K
Stock-Based Compensation (CF)	-	386K	-	283K	406K
Other Operating Activities, Total	-	-	-	-143K	16.55K
Change In Accounts Receivable	-	-	-	-538	-142K
Change In Inventories	-	-	-	111K	-314K
Change In Accounts Payable	79.03K	-9.88K	29.72K	498K	2.27M
Change In Income Taxes	-	-	-	2.92K	265K
Change in Other Net Operating Assets	-	20.5K	-78.75K	95.97K	46.25K
Cash from Operations	1.58K	-120K	-519K	125K	2.01M
Capital Expenditure	-	-	-	-6.89K	-87.6K
Cash Acquisitions	-	-	-	-16.86M	-12.61M
Other Investing Activities, Total	-	-	-	-	-1.02M
Cash from Investing	-	-	-	-16.86M	-13.72M
Long-Term Debt Issued, Total	-	-	-	-	3.16M
Total Debt Issued	-	-	-	-	3.16M
Long-Term Debt Repaid, Total	-	-	-	-107K	-323K
Total Debt Repaid	-	-	-	-107K	-323K
Issuance of Common Stock	3M	2M	27.84K	27.49M	21.44M
Other Financing Activities, Total	-61.5K	-126K	-	-	432K
Cash from Financing	2.94M	1.87M	27.84K	27.38M	24.71M
Net Change in Cash	2.94M	1.75M	-492K	10.64M	13M
Supplemental Items
Levered Free Cash Flow	-	44.92K	-410K	-544K	1.85M
Unlevered Free Cash Flow	-	44.92K	-410K	-535K	1.89M
Change In Net Working Capital	-	-10.62K	49.03K	108K	-1.4M
Net Debt Issued / Repaid	-	-	-	-107K	2.84M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-	-18.85	-14.29	-5.29	-1.54
Return on Total Capital	-	-19.07	-14.47	-5.88	-1.75
Return On Equity %	-	-28.02	-18.85	-6.4	-3.43
Return on Common Equity	-	-28.02	-18.85	-6.21	-3.6
Margin Analysis
Gross Profit Margin %	-	-	-	37.69	39.72
SG&A Margin	-	-	-	55.22	39.2
EBITDA Margin %	-	-	-	-23.23	-1.98
EBITA Margin %	-	-	-	-24.44	-2.78
EBIT Margin %	-	-	-	-27.41	-5.92
Income From Continuing Operations Margin %	-	-	-	-18.14	-6.81
Net Income Margin %	-	-	-	-17.48	-7.09
Net Avail. For Common Margin %	-	-	-	-17.48	-7.09
Normalized Net Income Margin	-	-	-	-11.83	-2.78
Levered Free Cash Flow Margin	-	-	-	-9.39	8.86
Unlevered Free Cash Flow Margin	-	-	-	-9.23	9.03
Asset Turnover
Asset Turnover	-	-	-	0.31	0.41
Fixed Assets Turnover	-	-	-	-	4.4
Receivables Turnover (Average Receivables)	-	-	-	-	27.05
Inventory Turnover (Average Inventory)	-	-	-	-	6.27
Short Term Liquidity
Current Ratio	37.98	166.01	50.24	8.59	5.14
Quick Ratio	37.2	166.01	48.54	7.79	4.67
Operating Cash Flow to Current Liabilities	0.06	-7.3	-11.25	0.07	0.35
Days Sales Outstanding (Average Receivables)	-	-	-	-	13.49
Days Outstanding Inventory (Average Inventory)	-	-	-	-	58.22
Average Days Payable Outstanding	-	-	-	-	87.92
Cash Conversion Cycle (Average Days)	-	-	-	-	-16.21
Long Term Solvency
Total Debt/Equity	-	-	-	3.12	8.7
Total Debt / Total Capital	-	-	-	3.02	8
LT Debt/Equity	-	-	-	2.63	7.65
Long-Term Debt / Total Capital	-	-	-	2.55	7.04
Total Liabilities / Total Assets	2.63	0.6	1.99	13.19	20.28
EBIT / Interest Expense	-	-	-	-111.38	-21.77
EBITDA / Interest Expense	-	-	-	-91.06	-5.23
(EBITDA - Capex) / Interest Expense	-	-	-	-91.54	-6.77
Total Debt / EBITDA	-	-	-	-0.73	-15.28
Net Debt / EBITDA	-	-	-	9.19	71.73
Total Debt / (EBITDA - Capex)	-	-	-	-0.73	-11.8
Net Debt / (EBITDA - Capex)	-	-	-	9.14	55.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-	260.57
Gross Profit, 1 Yr. Growth %	-	-	-	-	279.89
EBITDA, 1 Yr. Growth %	-	-	-	-	-69.19
EBITA, 1 Yr. Growth %	-	607.52	2.62	145.02	-59
EBIT, 1 Yr. Growth %	-	607.52	2.62	174.82	-22.08
Earnings From Cont. Operations, 1 Yr. Growth %	-	567.6	-9.02	123.4	35.31
Net Income, 1 Yr. Growth %	-	567.6	-9.02	115.3	46.26
Normalized Net Income, 1 Yr. Growth %	-	567.6	-9.02	133.07	-15.12
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-10.27	-46.58	-4.49
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	272.71
Inventory, 1 Yr. Growth %	-	-	-	-	106.02
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	-	36.19
Total Assets, 1 Yr. Growth %	-	173.19	-15.1	1.42K	86.23
Tangible Book Value, 1 Yr. Growth %	-	178.89	-16.29	503.86	58.16
Common Equity, 1 Yr. Growth %	-	178.89	-16.29	1.23K	71.11
Cash From Operations, 1 Yr. Growth %	-	-7.73K	332.22	-124.06	1.51K
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	1.17K
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-1.01K	32.59	-440.37
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-1.01K	30.42	-452.68
Compound Annual Growth Rate Over Two Years
EBITA, 2 Yr. CAGR %	-	-	169.46	58.57	0.23
EBIT, 2 Yr. CAGR %	-	-	169.46	67.94	46.34
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	146.45	42.56	73.86
Net Income, 2 Yr. CAGR %	-	-	146.45	39.95	77.45
Normalized Net Income, 2 Yr. CAGR %	-	-	146.45	45.61	40.65
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	-30.77	-28.57
Total Assets, 2 Yr. CAGR %	-	-	52.29	258.9	431.57
Tangible Book Value, 2 Yr. CAGR %	-	-	52.79	124.83	209.05
Common Equity, 2 Yr. CAGR %	-	-	52.79	234.19	377.8
Cash From Operations, 2 Yr. CAGR %	-	-	1.72K	1.97	96.53
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	248.01	112.44
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	245.15	114.47
Compound Annual Growth Rate Over Three Years
EBITA, 3 Yr. CAGR %	-	-	-	161.05	1.02
EBIT, 3 Yr. CAGR %	-	-	-	171.23	30.01
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	138.51	40.1
Net Income, 3 Yr. CAGR %	-	-	-	135.59	42.03
Normalized Net Income, 3 Yr. CAGR %	-	-	-	141.9	21.64
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-22.93
Total Assets, 3 Yr. CAGR %	-	-	-	227.7	188.4
Tangible Book Value, 3 Yr. CAGR %	-	-	-	141.57	99.96
Common Equity, 3 Yr. CAGR %	-	-	-	214.64	167.36
Cash From Operations, 3 Yr. CAGR %	-	-	-	329.71	155.58
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	245.44
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	247.64